Long-Term Liabilities: The sum of all non-current liabilities.
Vanda Pharmaceuticals Inc. (VNDA) had Long-Term Liabilities of $17.18M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$51.72M |
|
$-48.57M |
|
$3.16M |
|
$48.56M |
|
$101.94M |
|
$-50.22M |
|
$1.80M |
|
$-48.42M |
|
$-48.42M |
|
$-48.57M |
|
$-48.57M |
|
$-48.57M |
|
$-48.57M |
|
$-50.22M |
|
$-46.83M |
|
59.46M |
|
59.46M |
|
$-0.82 |
|
$-0.82 |
|
| Balance Sheet Financials | |
$293.17M |
|
$2.25M |
|
$140.36M |
|
$433.52M |
|
$135.58M |
|
$3.79M |
|
|
Long-Term Liabilities |
$17.18M |
$152.76M |
|
$280.76M |
|
$165.66M |
|
$280.76M |
|
60.13M |
|
| Cash Flow Statement Financials | |
$-50.22M |
|
$20.23M |
|
$-0.78M |
|
$85.32M |
|
$54.50M |
|
$-30.82M |
|
$2.56M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.16 |
|
-- |
|
-- |
|
0.01 |
|
0.01 |
|
93.89% |
|
-97.11% |
|
-97.11% |
|
-- |
|
-93.63% |
|
-93.91% |
|
$-50.44M |
|
-- |
|
-- |
|
-- |
|
0.12 |
|
1.86 |
|
0.91 |
|
98.98 |
|
-17.30% |
|
-29.32% |
|
-11.20% |
|
-17.07% |
|
$4.67 |
|
$-0.85 |
|
$-0.84 |
|